Table 3 Hazard ratio of RVO in ESRD group and KT group.

From: Impact of kidney transplantation on the risk of retinal vein occlusion in end-stage renal disease

Outcomes

Groups

Rate

Model 1

Model 2

Model 3

Per 1000 patient-years

Hazard ratio (95% CI)

P-value

Hazard ratio (95% CI)

P-value

Hazard ratio (95% CI)

P-value

RVO, total

ESRD

5.68

1 (Ref.)

 

1 (Ref.)

 

1 (Ref.)

 

KT

2.74

0.49 (0.40, 0.59)

< 0.001

0.48 (0.40, 0.58)

< 0.001

0.47 (0.29, 0.58)

< 0.001

Non-ischemic RVO

ESRD

4.60

1 (Ref.)

 

1 (Ref.)

 

1 (Ref.)

 

KT

2.26

0.50 (0.4, 0.61)

< 0.001

0.49 (0.39, 0.60)

< 0.001

0.48 (0.39, 0.60)

< 0.001

Ischemic RVO

ESRD

1.07

1 (Ref.)

 

1 (Ref.)

 

1 (Ref.)

 

KT

0.48

0.46 (0.30, 0.72)

< 0.001

0.45 (0.29, 0.70)

< 0.001

0.44 (0.28, 0.70)

< 0.001

  1. Analysis was performed using Cox regression. Model 1: not adjusted; Model 2: adjusted with age, sex; Model 3: adjusted with age, sex, diabetes mellitus, hypertension, dyslipidemia, Charlson comorbidity index, income status.
  2. CI confidence interval, ESRD end stage renal disease, KT kidney transplantation, RVO renal vein occlusion.
Back to article page